-
Product Insights
NewTotal Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart. GlobalData's Medical Devices sector report, “Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Total Artificial Heart report...
-
Product Insights
NewContinuous Positive Airway Pressure (CPAP) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Continuous Positive Airway Pressure machine is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. Continuous Positive Airway Pressure devices provide a gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose which is connected to a nasal mask, nasal pillow or a full face mask. The mask must be carefully secured to the face so that no air escapes. This constant supply of air pressure...
-
Product Insights
NewPulse Oximeter Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Pulse oximeter system is a photoelectric instrument that measures oxygen saturation of blood noninvasively and continuously. A pulse oximeter consists of the monitor containing the batteries and display, and the probe that senses the pulse. GlobalData's Medical Devices sector report, “Pulse Oximeter Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Pulse Oximeter Systems pipeline products with comparative analysis of the products at various stages...
-
Sector Analysis
NewAmericas Food Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Americas Food Market Overview The Americas food market was valued at $1.28 trillion in 2023. The Americas was the second-largest market in the global food industry in 2023 and will garner a CAGR of more than 4% during 2023-2028. Americas Food Market Outlook 2023-2028 ($ Trillion) Buy the Full Report for more Insights on the Americas Food Market Forecast, Download a Free Sample The Americas food market report provides an overview of the current food industry scenario regarding the outlook...
-
Product Insights
NewLikelihood of Approval Analysis for Stroke
Overview How likely is it that the drugs in Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stroke Overview A stroke, also known as a cerebrovascular accident (CVA), is a...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ori-CAR-002 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ori-CAR-002 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ori-CAR-002 in Relapsed Multiple Myeloma Drug Details: Gene therapy is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ori-CAR-002 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ori-CAR-002 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ori-CAR-002 in Refractory Multiple Myeloma Drug Details: Gene therapy is under...
-
Product Insights
Hematological Disorders Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hematological Disorders Pipeline Market Report Overview The hematological disorders pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Hemostasis Tests ·       Coagulation Analyzers ·       Special Coagulation Tests ·       Hematology Tests ·       General Coagulation Tests Key...
-
Product Insights
Inhalers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Inhalers Pipeline Market Report Overview Inhalers deliver medication to the lungs. The inhalers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segment ·       Dry Powder Inhaler Devices Key Territories ·       The US ·       Europe ·       Australia...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ori-CAR-002 in Relapsed Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ori-CAR-002 in Relapsed Multiple Myeloma Drug Details: Gene therapy is under development for the treatment...